Addiction, Treatment and Recovery Caucus

Last updated

The Congressional Addiction, Treatment, and Recovery Caucus is bi-partisan caucus of the United States House of Representatives established in 2004 by Rep. Jim Ramstad. [1] The Caucus is currently co-chaired by Rep. Tim Ryan (D-OH) and Rep. John Fleming (R-LA).

Contents

According to the Caucus' webpage, its mission is:

"The mission of the Addiction Treatment and Recovery Caucus is to raise awareness and increase education regarding substance abuse and addiction treatment. According to the National Survey on Drug Use and Health, 23.5 million people aged 12 or older needed treatment for an illicit drug or alcohol abuse problem in 2009, and only 2.6 million—11.2 percent of those who needed treatment—received it at a specialty facility. Furthermore, substance abuse costs our nation more than $484 billion per year through lost earnings, health care expenditures, and costs associated with crime and accidents.This issue is also a pressing concern with our service men and women. The National Institute of Drug Abuse reports that combined with PTSD and TBI, substance abuse is a key concern with returning veterans. Prescription drug abuse has doubled among U.S. military personnel from 2002-2005 and tripled between 2005-2008. This caucus aims to help decrease the negative stigma that comes with these diseases and improve the lives of the people around the country suffering from addiction and substance abuse. " [2]

Current Membership

DemocratsRepublicans
Rep. John Barrow
Rep. Sheila Jackson Lee Rep. Shelley Moore Capito
Rep. Karen Bass Rep. John Carter
Rep. Tim Bishop Rep. Tom Cole
Rep. Bruce Braley Rep. John C. Fleming*
Rep. Mike Capuano Rep. Jim Gerlach
Lois Capps Rep. Tim Griffin
Rep. Tony Cardenas Rep. Tom Latham
Rep. Donna Christian-Christensen Rep. Gary Miller
Rep. William Lacy Clay, Jr Rep. Mike Rogers
Rep. Gerry Connolly Rep. Mike Simpson
Rep. Elijah Cummings Rep. Chris Smith
Rep. Danny Davis Rep. Lee Terry
Rep. Lloyd Doggett Rep. Joe Wilson
Rep. Eliot Engel
Rep. Gene Green
Rep. Rush Holt
Rep. Jared Huffman
Rep. Steve Israel
Rep. Henry "Hank" Johnson
Rep. Marcy Kaptur
Rep. William Keating
Rep. Joseph Kennedy
Rep. Ron Kind
Rep. James Langevin
Rep. Rick Larsen
Rep. Sheila Jackson Lee
Rep. Barbara Lee
Rep. Sander M. Levin
Rep. David Loebsack
Rep. Stephen F. Lynch
Rep. Carolyn Maloney
Rep. Jim Matheson
Rep. Carolyn McCarthy
Rep. Betty McCollum
Rep. Jim McDermott
Rep. Jim McGovern
Rep. Mike McIntyre
Rep. Gregory Meeks
Rep. Jim Moran
Rep. Grace Napolitano
Rep. Bill Pascrell, Jr.
Rep. Collin Peterson
Rep. David Price
Rep. Nick Rahall
Rep. Charles Rangel
Rep. Tim Ryan*
Rep. Jan Schakowsky
Rep. Loretta Sanchez
Rep. Carol Shea-Porter
Rep. Paul Tonko**
Rep. Chris Van Hollen
Rep. Henry Waxman
* Chairman** Vice-Chairman

See also

Caucus' of the United States Congress

Related Research Articles

Substance abuse Harmful use of a drug including alcohol

Substance abuse, also known as drug abuse, is the use of a drug in amounts or by methods which are harmful to the individual or others. It is a form of substance-related disorder. Differing definitions of drug abuse are used in public health, medical and criminal justice contexts. In some cases, criminal or anti-social behaviour occurs when the person is under the influence of a drug, and long-term personality changes in individuals may also occur. In addition to possible physical, social, and psychological harm, the use of some drugs may also lead to criminal penalties, although these vary widely depending on the local jurisdiction.

The Substance Abuse and Mental Health Services Administration is a branch of the U.S. Department of Health and Human Services. It is charged with improving the quality and availability of treatment and rehabilitative services in order to reduce illness, death, disability, and the cost to society resulting from substance abuse and mental illnesses. The Administrator of SAMHSA reports directly to the Secretary of the U.S. Department of Health and Human Services. SAMHSA's headquarters building is located outside of Rockville, Maryland.

Patrick J. Kennedy American politician

Patrick Joseph Kennedy II is an American politician and mental health advocate. From 1995 to 2011, he served as a Democratic member of the United States House of Representatives from Rhode Island's 1st congressional district. He is a former member of the President's Commission on Combatting Drug Addiction and the Opioid Crisis, and co-founder of One Mind.

Drug rehabilitation is the process of medical or psychotherapeutic treatment for dependency on psychoactive substances such as alcohol, prescription drugs, and street drugs such as cannabis, cocaine, heroin or amphetamines. The general intent is to enable the patient to confront substance dependence, if present, and stop substance misuse to avoid the psychological, legal, financial, social, and physical consequences that can be caused.

Jim Ramstad American politician

James Marvin Ramstad was an American lawyer and politician from Minnesota who served in the Minnesota Senate from 1981 to 1991 and in the United States House of Representatives from 1991 to 2009.

National Institute on Drug Abuse

The National Institute on Drug Abuse (NIDA) is a United States federal-government research institute whose mission is to "advance science on the causes and consequences of drug use and addiction and to apply that knowledge to improve individual and public health."

Drug courts are judicially supervised court dockets that provide a sentencing alternative of treatment combined with supervision for people living with serious substance use. Drug courts are problem-solving courts that take a public health approach using a specialized model in which the judiciary, prosecution, defense bar, probation, law enforcement, mental health, social service, and treatment communities work together to help addicted offenders into long-term recovery.

Substance dependence, also known as drug dependence, is a biopsychological situation where-by an individual's functionality is dependent on the necessitated re-consumption of a psychoactive substance, because of an adaptive state that has developed within the individual from psychoactive substance consumption, which results in the experience of withdrawal, which necessitates the re-consumption of the drug. A drug addiction, a distinct concept from substance dependence, is defined as compulsive, out-of-control drug use, despite negative consequences. An addictive drug is a drug which is both rewarding and reinforcing. ΔFosB, a gene transcription factor, is now known to be a critical component and common factor in the development of virtually all forms of behavioral and drug addictions, but not dependence.

Treatment Improvement Protocols (TIPs) are a series of best-practice manuals for the treatment of substance use and other related disorders. The TIP series is published by the Substance Abuse and Mental Health Services Administration (SAMHSA), an operational division of the U.S. Department of Health and Human Services.

SMART Recovery is an international non-profit organization that provides assistance to individuals seeking abstinence from addiction. SMART stands for Self-Management and Recovery Training. The SMART approach is secular and research-based, using cognitive behavioral therapy (CBT) and non-confrontational motivational methods.

John Fleming (American politician) American politician, physician, military veteran, and businessman

John Calvin Fleming Jr. is an American politician, physician, military veteran, and businessman. After leaving Congress in 2017, he served for two years in the administration as Deputy Assistant Secretary for Health Information Technology Reform and then served as Assistant Secretary of Commerce for Economic Development from March 2019 to 2020. In March 2020, he was appointed to a position in the White House as Assistant to the President for Planning and Implementation.

The California Department of Alcohol and Drug Programs (ADP) was a California state agency concerned with substance abuse prevention and treatment. Created by the California Legislature in 1978, ADP brought together the Governor's Office of Alcoholism and the California Department of Health's Division of Substance Abuse to form the single state authority for substance abuse prevention and treatment, and is currently within the auspices of the California Health and Human Services Agency. In this capacity, ADP provided leadership and policy coordination for the planning, development, implementation, and evaluation of a comprehensive statewide system of alcohol and other drug (AOD) prevention, treatment and recovery services. As of July 1, 2013, functions of ADP were transferred to the Department of Health Care Services.

Substance use disorder Continual use of drugs (including alcohol) despite detrimental consequences

Substance use disorder (SUD) is the persistent use of drugs despite substantial harm and adverse consequences. Substance use disorders are characterized by an array of mental/emotional, physical, and behavioral problems such as chronic guilt; an inability to reduce or stop consuming the substance(s) despite repeated attempts; driving while intoxicated; and physiological withdrawal symptoms. Drug classes that are involved in SUD include: alcohol; cannabis; phencyclidine and other hallucinogens, such as arylcyclohexylamines; inhalants; opioids; sedatives, hypnotics, or anxiolytics; stimulants; tobacco; and other or unknown substances.

Addiction Disease resulting in compulsive engagement in rewarding stimuli despite adverse consequences

Addiction is a biopsychosocial disorder characterized by compulsive engagement in rewarding stimuli despite adverse consequences. Despite the involvement of a number of psychosocial factors, a biological process—one that is induced by repeated exposure to an addictive stimulus—is the core pathology that drives the development and maintenance of an addiction, according to the "brain disease model" of addiction. However, some scholars who study addiction argue that the brain disease model is incomplete and misleading.

Michael Botticelli

Michael P. Botticelli is an American public health official who served as the director of the White House Office of National Drug Control Policy (ONDCP) from March 2014 until the end of President Obama's term. He was named acting director after the resignation of Gil Kerlikowske, and received confirmation from the United States Senate in February 2015. Prior to joining ONDCP, he worked in the Massachusetts Department of Public Health. Following completion of his service as ONDCP Director, he became the executive director of the Grayken Center for Addiction Medicine at the Boston Medical Center.

David Joyce (politician) American politician

David Patrick Joyce is an American politician and former prosecutor who has served as the United States Representative for Ohio's 14th congressional district since 2013. An attorney, Joyce was previously the prosecutor of Geauga County, Ohio. He is a member of the Republican Party.

Elizabeth Esty

Elizabeth Esty is an American politician who served as a U.S. Representative from Connecticut's 5th congressional district from 2013 to 2019. A Democrat, she previously was a member of the Connecticut House of Representatives, representing the 103rd Assembly District, which consisted of Cheshire and parts of Hamden and Wallingford. She also served two terms on the Cheshire Town Council. The 5th congressional district spans central and northwest Connecticut, including Waterbury, Danbury, New Britain, Meriden, Torrington, Litchfield County, the Farmington Valley, Newtown, and Esty's hometown of Cheshire.

Discrimination against drug addicts is a form of discrimination against people who suffer from a drug addiction. In the process of stigmatization, drug addicts are stereotyped as having a particular set of undesirable traits, in turn causing other individuals to act in a fearful or prejudicial manner toward them. Drug use discrimination also leads to many users being secretive about drug use. As it relates to healthcare stigmatizing attitudes surrounding drug use can cause barriers to treatment uptake and engagement. In some of its manifestations, discrimination against drug addicts involves a violation of human rights.

Tim Ryan (recovery advocate)

Tim Ryan is an American activist, drug abuse interventionist, author and speaker. He is the Founder and Executive director of “A Man in Recovery” foundation. According to the National Safety Council, Ryan is notable for his position in favor of Drug policy reform and as a proponent of legislative change in American drug policy. His work was the subject of the A&E series “Dope Man” in July 2017. Ryan is also the author of the book “From Dope to Hope: A Man in Recovery” published in 2017.

References

  1. "U.S. Representative Jim Ramstad Announces New Congressional Recovery Caucus In Betty Ford Center Address" . Retrieved 5 Jul 2013.
  2. "Congressional Addiction, Treatment and Recovery Caucus". Archived from the original on 15 July 2013. Retrieved 5 Jul 2013.